| Date | Description |
|---|
| 2024-03-31 |
delete ceo Dirk Beher |
| 2024-03-31 |
delete chairman Peter Van Vlasselaer |
| 2024-03-31 |
delete cso Dirk Beher |
| 2024-03-31 |
delete founder Dirk Beher |
| 2024-03-31 |
delete otherexecutives Peter Van Vlasselaer |
| 2024-03-31 |
insert ceo Barbara Angehrn Pavik |
| 2024-03-31 |
insert chairman Abbas Hussain |
| 2024-03-31 |
delete person Pearl Fang |
| 2024-03-31 |
delete person Peter Van Vlasselaer |
| 2024-03-31 |
insert person Abbas Hussain |
| 2024-03-31 |
insert person Barbara Angehrn Pavik |
| 2024-03-31 |
update person_description Dirk Beher => Dirk Beher |
| 2024-03-31 |
update person_title Dirk Beher: Member of the Board of Directors; Founder; CSO; Chief Executive Officer => Executive; Member of the Board; Chief Scientific Advisor and Founder |
| 2024-03-31 |
update person_title Ryan Schubert: Senior Vice President of Translational Medicine and Clinical Strategy => Senior Vice President Research and Development |
| 2023-05-28 |
update robots_txt_status new.asceneuron.com: 0 => 200 |
| 2023-03-12 |
delete person Deborah Harland |
| 2023-03-12 |
insert person Amit Shah |
| 2022-11-05 |
delete person Vanessa Malier |
| 2022-09-04 |
delete investor_pages_linkeddomain sofinnova.fr |
| 2022-09-04 |
delete person Jeanne Bolger |
| 2022-09-04 |
insert investor_pages_linkeddomain sofinnovapartners.com |
| 2022-09-04 |
insert person Lior Teitelbaum |
| 2022-09-04 |
update person_title Vanessa Malier: Managing Partner at Kurma Partners. Scientist; Director, Kurma Partners => Managing Partner at Kurma Partners. Scientist; Board Observer, Kurma Partners |
| 2022-08-05 |
update person_description Dr. Ryan Schubert => Ryan Schubert |
| 2022-08-05 |
update person_title Ryan Schubert: Senior Director & Head of Translational Medicine => Senior Vice President of Translational Medicine and Clinical Strategy |
| 2022-04-06 |
update person_description Henrijette Richter => Henrijette Richter |
| 2022-04-06 |
update person_title Henrijette Richter: Managing Partner at Sofinnova Partners; Director, Sofinnova Partners => Director, Sofinnova Partners; Member of the Capital Funds Team at Sofinnova |
| 2021-12-12 |
delete ceo Dirk Beher |
| 2021-12-12 |
delete founder Dirk Beher |
| 2021-12-12 |
delete otherexecutives Catherine Moukheibir |
| 2021-12-12 |
delete otherexecutives Dirk Beher |
| 2021-12-12 |
delete alias Asceneuron SA |
| 2021-12-12 |
delete index_pages_linkeddomain linkedin.com |
| 2021-12-12 |
delete index_pages_linkeddomain twitter.com |
| 2021-12-12 |
delete industry_tag clinical stage biotech |
| 2021-12-12 |
delete person Catherine Moukheibir |
| 2021-12-12 |
delete person Dirk Beher |
| 2021-12-12 |
insert alias asceneuron.com |
| 2021-09-18 |
insert ceo Dirk Beher |
| 2021-09-18 |
insert founder Dirk Beher |
| 2021-09-18 |
insert otherexecutives Catherine Moukheibir |
| 2021-09-18 |
insert otherexecutives Dirk Beher |
| 2021-09-18 |
delete alias asceneuron.com |
| 2021-09-18 |
insert alias Asceneuron SA |
| 2021-09-18 |
insert index_pages_linkeddomain linkedin.com |
| 2021-09-18 |
insert index_pages_linkeddomain twitter.com |
| 2021-09-18 |
insert industry_tag clinical stage biotech |
| 2021-09-18 |
insert person Catherine Moukheibir |
| 2021-09-18 |
insert person Dirk Beher |
| 2021-06-11 |
delete ceo Dirk Beher |
| 2021-06-11 |
delete founder Dirk Beher |
| 2021-06-11 |
delete otherexecutives Dirk Beher |
| 2021-06-11 |
delete otherexecutives Dr Eric Yuen |
| 2021-06-11 |
delete alias Asceneuron SA |
| 2021-06-11 |
delete index_pages_linkeddomain linkedin.com |
| 2021-06-11 |
delete industry_tag biotech |
| 2021-06-11 |
delete person Dirk Beher |
| 2021-06-11 |
delete person Dr Eric Yuen |
| 2021-04-17 |
insert ceo Dirk Beher |
| 2021-04-17 |
insert founder Dirk Beher |
| 2021-04-17 |
insert otherexecutives Dirk Beher |
| 2021-04-17 |
insert otherexecutives Dr Eric Yuen |
| 2021-04-17 |
insert alias Asceneuron SA |
| 2021-04-17 |
insert index_pages_linkeddomain linkedin.com |
| 2021-04-17 |
insert industry_tag biotech |
| 2021-04-17 |
insert person Dirk Beher |
| 2021-04-17 |
insert person Dr Eric Yuen |
| 2021-01-22 |
update description |
| 2020-09-21 |
delete ceo Dirk Beher |
| 2020-09-21 |
delete chairman Peter Van Vlasselaer |
| 2020-09-21 |
delete founder Dirk Beher |
| 2020-09-21 |
delete otherexecutives Dirk Beher |
| 2020-09-21 |
delete otherexecutives Dr Eric Yuen |
| 2020-09-21 |
delete otherexecutives Peter Van Vlasselaer |
| 2020-09-21 |
delete alias Asceneuron SA |
| 2020-09-21 |
delete index_pages_linkeddomain linkedin.com |
| 2020-09-21 |
delete industry_tag biotech |
| 2020-09-21 |
delete person Dirk Beher |
| 2020-09-21 |
delete person Dr Eric Yuen |
| 2020-09-21 |
delete person Peter Van Vlasselaer |
| 2020-03-08 |
insert person Dr. Ryan Schubert |
| 2020-01-07 |
update person_title Rolf Pokorny: Head of Clinical Development; Head => Head; Head of Early Clinical Development |
| 2019-12-07 |
delete otherexecutives Dr. Thomas C. Wessel |
| 2019-12-07 |
delete person Dr. Thomas C. Wessel |
| 2019-12-07 |
insert person Pearl Fang |
| 2019-12-07 |
insert person Ruhi AHMED |
| 2019-06-07 |
delete otherexecutives Debbie Allen |
| 2019-06-07 |
insert otherexecutives Dr Eric Yuen |
| 2019-06-07 |
delete person Debbie Allen |
| 2019-06-07 |
delete person Dr. Franz F. Hefti |
| 2019-06-07 |
insert person Dr Eric Yuen |
| 2019-05-08 |
update website_status FailedRobotsLimitReached => OK |
| 2019-03-09 |
update website_status FailedRobots => FailedRobotsLimitReached |